UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 215.30
-1.20 (-0.55%)
Aug 31, 2026, 5:35 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €41.28 billion as of August 31, 2026. Its market cap has increased by 8.71% in one year.
Market Cap
41.28B
Enterprise Value
44.10B
Revenue
8.52B
Ranking
n/a
PE Ratio
19.12
Stock Price
€215.30
ChartMarket Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 41.28B, an increase of 4,534.56%. That is a compound annual growth rate of 12.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 41.28B | -8.94% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 55.98B |
| Financière de Tubize | 8.30B |
| Onward Medical | 171.74M |
| Hyloris Pharmaceuticals | 123.76M |
| European Medical Solutions | 14.81M |
| Celyad Oncology | 11.68M |
| BioSenic | 1.31M |
| Oxurion NV | 230.60K |